Tissue Repair (ASX:TRP) — Material Events
ASX:TRP · 5 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Tissue Repair Accelerates Global Expansion Amid Phase 3 Trial ChallengesMedium
Tissue Repair advances Phase 3 trials, expands TR Pro+® distribution, reports $12.3M cash and strong sales growth
31 July 2025
·Appendix 4C Quarterly Cashflow Report and Activity Update
·80
Tissue Repair Eyes July Milestone as TR987 Trial Slows and TR Pro+ Sales PivotMedium
Tissue Repair updates slow Phase 3 trial progress, advances TR Pro+ commercialization and regulatory filings
30 Jan 2026
·Appendix 4C Quarterly Cash Flow Report
·75
Tissue Repair Accelerates Phase 3 Trials and Preps for 2026 Commercial LaunchMedium
Tissue Repair advances Phase 3 trials, regulatory filings, and commercial rollout with $10.3M cash
29 Oct 2025
·Appendix 4C Quarterly Cashflow Report
·75
No articles in this tier for the last 12 months.